| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 587 | 5.412 | 32.366 | 43.353 | 69.708 | 21.059 |
| Total Income - EUR | - | - | - | 0 | 2.273 | 10.373 | 37.218 | 43.353 | 69.716 | 37.463 |
| Total Expenses - EUR | - | - | - | 5 | 10.910 | 27.037 | 34.400 | 40.262 | 66.224 | 10.018 |
| Gross Profit/Loss - EUR | - | - | - | -5 | -8.637 | -16.664 | 2.818 | 3.091 | 3.492 | 27.445 |
| Net Profit/Loss - EUR | - | - | - | -5 | -8.643 | -16.716 | 2.538 | 2.657 | 1.765 | 23.141 |
| Employees | - | - | - | 0 | 3 | 5 | 5 | 5 | 4 | 1 |
Check the financial reports for the company - Flavixtreme S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 38.774 | 33.078 | 27.493 | 22.711 | 17.790 | 12.866 |
| Current Assets | - | - | - | 103 | 66 | 498 | 359 | 650 | 4.932 | 34.745 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 14 | 296 | 277 | 551 | 334 | 20.436 |
| Cash | - | - | - | 103 | 52 | 203 | 82 | 99 | 4.598 | 14.309 |
| Shareholders Funds | - | - | - | 103 | -8.542 | -25.096 | -22.002 | -19.413 | -17.589 | 5.651 |
| Social Capital | - | - | - | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | - | - | 0 | 6.922 | 23.940 | 20.744 | 13.574 | 11.200 | 17.836 |
| Income in Advance | - | - | - | 0 | 40.460 | 34.732 | 29.110 | 29.200 | 29.111 | 24.124 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9313 - 9313" | |||||||||
| CAEN Financial Year |
9313
|
|||||||||
Comments - Flavixtreme S.r.l.